Page last updated: 2024-09-03

imatinib mesylate and Hyperpigmentation

imatinib mesylate has been researched along with Hyperpigmentation in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (12.50)	29.6817
2010's	18 (75.00)	24.3611
2020's	3 (12.50)	2.80

Authors

Authors	Studies
Martínez de Lagrán Álvarez de Arcaya, Z; Piqueres, T; Rosés-Gibert, P	1
Hakim, N; Rehman, H; Saif, MW; Seetharamu, N; Sugarman, R	1
Carrozzo, M; Donnell, CC; Walton, RL	1
Beets, GL; Farag, S; Steeghs, N; van Akkooi, ACJ; van Boven, HH; van der Kolk, LE; Wilmink, JW	1
Dogra, S; Handa, S; Khadwal, A; Kumari, S; Lad, D; Malhotra, P; Prakash, G; Suri, V; Varma, S; Vinay, K; Yanamandra, U	1
Kalogirou, EM; Sklavounou, A; Tosios, KI	1
Di Tullio, F; Mandel, VD; Padalino, C; Pellacani, G; Scotti, R	1
Cassier, P; Kluger, N; Ruffion, N	1
Kaune, KM; Lueken, N; Zutt, M	1
Chua, SH; Kok, WL	1
Abreu, LG; da Silva, TA; de Azevedo Branco, LG; Fonseca, FP; Magalhães, GHR; Mesquita, RA; Oliveira, SR; Rocha, AL; Travassos, DV	1
Aiba, S; Kagimoto, Y; Kikuchi, K; Mizuashi, M	1
Anzalone, CL; Cohen, PR; Cortes, JE; Kurzrock, R	1
Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E	1
Bailey, BM; Creedon, A; Lyne, A	1
Alexandrescu, DT; Dasanu, CA; Farzanmehr, H; Kauffman, L	1
Benekli, M; Bilge Yilmaz, I; Buyukberber, S; Coskun, U; Demirci, U; Erdem, O; Ozturk, B	1
Bakhshi, S; Gupta, R; Kumar, L; Kumar, R; Medhi, K; Raina, V; Sharma, A	1
Abreu, MH; Gomez, RS; Resende, RG; Silva, ME; Teixeira, RG; Vasconcelos, Fde O	1
Balagula, Y; Maki, RG; Myskowski, PL; Pulitzer, MP	1
Field, EA; Rajlawat, BP; Steele, JC; Triantafyllou, A	1
Catalano, A; Chong, L; Iland, H; Khoo, TL; Supple, S; Yeoh, SC; Yeung, S	1
Bakshi, A; Biswas, G; Deshmukh, C; Parikh, PM; Prasad, N; Sastry, PS	1
Bakhshi, S; Singh, N	1

Reviews

6 review(s) available for imatinib mesylate and Hyperpigmentation

Article	Year
The blue palate-A case series of imatinib-related oral pigmentation and literature review. Oral surgery, oral medicine, oral pathology and oral radiology, 2021, Volume: 131, Issue:1 Topics: Antineoplastic Agents; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Pigmentation	2021
Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview. Familial cancer, 2018, Volume: 17, Issue:2 Topics: Adult; Age of Onset; Antineoplastic Agents; Exons; Female; Gastrointestinal Stromal Tumors; Genetic Predisposition to Disease; Genetic Testing; Germ-Line Mutation; Humans; Hyperpigmentation; Imatinib Mesylate; Neoplastic Syndromes, Hereditary; Proto-Oncogene Proteins c-kit; Rectum; Skin; Stomach; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2018
Drug-associated hyperpigmentation of the oral mucosa: report of four cases. Oral surgery, oral medicine, oral pathology and oral radiology, 2018, Volume: 125, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Biopsy; Female; Humans; Hydroxychloroquine; Hyperpigmentation; Imatinib Mesylate; Male; Middle Aged; Minocycline; Mouth Mucosa; Protein Kinase Inhibitors	2018
Imatinib-induced diffuse hyperpigmentation of the oral mucosa, the skin, and the nails in a patient affected by chronic myeloid leukemia: report of a case and review of the literature. International journal of dermatology, 2018, Volume: 57, Issue:7 Topics: Antineoplastic Agents; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mouth Mucosa; Nails; Skin	2018
Association of oral mucosa hyperpigmentation with imatinib mesylate use: a cross-sectional study and a systematic literature review. Clinical oral investigations, 2019, Volume: 23, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brazil; Cross-Sectional Studies; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mouth Mucosa; Young Adult	2019
[Oral toxicity of targeted anticancer therapies]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:5 Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases	2014

Trials

1 trial(s) available for imatinib mesylate and Hyperpigmentation

Article	Year
Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country. Leukemia & lymphoma, 2010, Volume: 51, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Child; Female; Follow-Up Studies; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; India; Kaplan-Meier Estimate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutropenia; Piperazines; Pyrimidines; Thrombocytopenia; Treatment Outcome; Young Adult	2010

Article

Year

Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country.

Leukemia & lymphoma, 2010, Volume: 51, Issue:10

Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Child; Female; Follow-Up Studies; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; India; Kaplan-Meier Estimate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutropenia; Piperazines; Pyrimidines; Thrombocytopenia; Treatment Outcome; Young Adult

2010

Other Studies

17 other study(ies) available for imatinib mesylate and Hyperpigmentation

Article	Year
Familial progressive hyperpigmentation: Skin lightening due to imatinib. Medicina clinica, 2022, 10-14, Volume: 159, Issue:7 Topics: Humans; Hyperpigmentation; Imatinib Mesylate; Skin; Skin Pigmentation	2022
Hyperpigmentation due to imatinib: A rare case of cutaneous involvement. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:6 Topics: Aged; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hyperpigmentation; Imatinib Mesylate; Protein Kinase Inhibitors	2020
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients. International journal of dermatology, 2018, Volume: 57, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cross-Sectional Studies; Drug Eruptions; Edema; Eye Diseases; Female; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Sex Factors; Skin Diseases, Vesiculobullous; Time Factors; Young Adult	2018
[Imatinib-induced pigmentation of the hard palate]. Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:11 Topics: Humans; Hyperpigmentation; Imatinib Mesylate; Male; Middle Aged; Palate, Hard; Protein Kinase Inhibitors	2018
A Large Gray-Blue Macule on the Hard Palate as an Adverse Effect of Imatinib. Deutsches Arzteblatt international, 2019, 02-08, Volume: 116, Issue:6 Topics: Aged; Antineoplastic Agents; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Palate, Hard; Skin	2019
Picosecond 755-nm Alexandrite Lasers Are an Effective Treatment for Imatinib-Induced Hyperpigmentation. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019, Volume: 45, Issue:4 Topics: Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Lasers, Solid-State; Treatment Outcome	2019
Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate. International journal of dermatology, 2014, Volume: 53, Issue:3 Topics: Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hyperpigmentation; Imatinib Mesylate; Lichenoid Eruptions; Middle Aged; Piperazines; Pyrimidines	2014
Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia. Dermatology online journal, 2014, Jan-15, Volume: 20, Issue:1 Topics: Aged; Antineoplastic Agents; Benzamides; Blepharoplasty; Drug Administration Schedule; Ecchymosis; Edema; Eyelid Diseases; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Postoperative Complications; Postoperative Hemorrhage; Preoperative Care; Protein Kinase Inhibitors; Purpura; Pyrimidines; Retrospective Studies; Skin Transplantation	2014
Mucosal pigmentation of the hard palate in a patient taking imatinib. BMJ case reports, 2015, Apr-16, Volume: 2015 Topics: Antineoplastic Agents; Female; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mouth Diseases; Mouth Mucosa; Palate, Hard	2015
Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST. Dermatology online journal, 2008, Jul-15, Volume: 14, Issue:7 Topics: Benzamides; Biopsy, Needle; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Hyperpigmentation; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Risk Assessment	2008
Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biopsy; Gastrointestinal Stromal Tumors; Histamine Antagonists; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Keratoderma, Palmoplantar; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rosacea; Skin; Skin Pigmentation; Sunitinib; Treatment Outcome	2011
Imatinib-associated hyperpigmentation of the palate in post-HSCT patient. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2012, Volume: 40, Issue:5 Topics: Adult; Antineoplastic Agents; Benzamides; Ear Diseases; Ear, External; Facial Dermatoses; Hematopoietic Stem Cell Transplantation; Humans; Hyperpigmentation; Imatinib Mesylate; Male; Maxillary Diseases; Neoplasms, Second Primary; Neurofibromatosis 1; Nose Diseases; Palate, Hard; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyrimidines; Tissue Conditioning, Dental	2012
Pigmentary changes in a patient treated with imatinib. Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:9 Topics: Adult; Antineoplastic Agents; Benzamides; Dermatofibrosarcoma; Follow-Up Studies; Hair Color; Humans; Hyperpigmentation; Imatinib Mesylate; Male; Piperazines; Pyrimidines; Skin Pigmentation	2011
Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib. Clinical and experimental dermatology, 2012, Volume: 37, Issue:4 Topics: Antineoplastic Agents; Benzamides; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2012
Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT. Leukemia & lymphoma, 2013, Volume: 54, Issue:1 Topics: Antineoplastic Agents; Base Sequence; Benzamides; Female; Genetic Variation; Heterozygote; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mutation; Palate, Hard; Piperazines; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines	2013
Dermatological toxicity of imatinib mesylate. The Journal of the Association of Physicians of India, 2005, Volume: 53 Topics: Adult; Benzamides; Erythema; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2005
Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia. Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:3 Topics: Adolescent; Benzamides; Female; Gingival Diseases; Humans; Hyperpigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Tooth Diseases; Treatment Outcome	2007